✦ LIBER ✦

Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia

✍ Scribed by Peggy S. Weintrub; Gerald Schiffman; Joseph E. Addiego Jr.; Katherine K. Matthay; Elliot Vichinsky; Robert Johnson; Bertram Lubin; William C. Mentzer; Arthur J. Ammann

Book ID: 119460648
Publisher: Elsevier Science
Year: 1984
Tongue: English
Weight: 271 KB
Volume: 105
Category: Article
ISSN: 1097-6833
DOI: 10.1016/s0022-3476(84)80124-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Seroprevalence of Hepatitis B and Hepati

Seroprevalence of Hepatitis B and Hepatitis C in Patients with Thalassemia and Sickle Cell Anemia in a Long-term Follow-up

✍ Sabahattin Ocak; Hasan Kaya; Meryem Cetin; Edip Gali; Muge Ozturk 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Increased serum opsonic activity and ant

Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunization

✍ David S. Chudwin; Diane W. Wara; Katherine K. Matthay; Mary H. Caulfield; Gerald 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 389 KB

Manual erythroexchange for chronic trans

Manual erythroexchange for chronic transfusion therapy in patients with sickle cell syndromes unresponsive to hydroxyurea: A long-term follow-up

✍ Paola Carrara; Manuela Balocco; Valeria Pinto; Francesca Olcese; Anna Soldà; Pao 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 2 views

## Nothing to report. a Costs estimates for a 55-Kg patient based on: STT 5 2: filtered, washed, without buffy coat red blood cell units (250 ml Ht 80%)/ 4 week ? 249/ RBC U € 3 2 5 498 €. Desferoxamine f. 2g ? 11.05 € (40 mg/kg 3 5 days/week 5 11 g/week ? 5 f/ week 3 52 weeks/year). MEEX 5 2: fil

Long-term follow-up of allogeneic stem c

Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin

✍ N. Kröger; T. Zabelina; H. Renges; W. Krüger; U. Kordes; J. Rischewski; J. Schru 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 62 KB

Allogenic hematopoietic stem-cell transp

Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma : Long-term follow-up

✍ Avichai Shimoni; Izhar Hardan; Francis Ayuk; Georgia Schilling; Djorde Atanackov 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

## Abstract ## BACKGROUND: Allogeneic stem cell transplantation (SCT) with myeloablative conditioning is potentially curative therapy for myeloma, but is reportedly associated with a high risk of nonrecurrence mortality (NRM). Reduced‐intensity conditioning (RIC) allows for the reduction of NRM, b

Allogeneic Hematopoietic Stem Cell Trans

Allogeneic Hematopoietic Stem Cell Transplantation With Reduced-Intensity Conditioning In Patients With Refractory And Relapsing Multiple Myeloma: Long-Term Follow-Up

✍ A. Shimoni; I. Hardan; F. Ayuk; G. Schilling; D. Atanackovic; W. Zeller; N. Shem 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 77 KB